Human Health and Performance Risks of Space Exploration Missions
Chapter 3
An image should appear at this position in the text. To use the entire page scan as a placeholder, edit this page and replace "{{missing image}}" with "{{raw image|Risk of performance errors due to sleep loss, circadian desynchronization, fatigue, and work overload.pdf/13}}". Otherwise, if you are able to provide the image then please do so. For guidance, see Wikisource:Image guidelines and Help:Adding images. |
Figure 3-4. Image of an Actiwatch activity monitor that is shown next to a ruler to demonstrate the size of the Actiwatch.
An image should appear at this position in the text. To use the entire page scan as a placeholder, edit this page and replace "{{missing image}}" with "{{raw image|Risk of performance errors due to sleep loss, circadian desynchronization, fatigue, and work overload.pdf/13}}". Otherwise, if you are able to provide the image then please do so. For guidance, see Wikisource:Image guidelines and Help:Adding images. |
Figure 3-5. With most of his body tucked away in a sleeping bag, astronaut Daniel Tani, Expedition 16 flight engineer, poses for a photograph near two extravehicular mobility unit spacesuits in the Quest Airlock of the ISS.
An image should appear at this position in the text. To use the entire page scan as a placeholder, edit this page and replace "{{missing image}}" with "{{raw image|Risk of performance errors due to sleep loss, circadian desynchronization, fatigue, and work overload.pdf/13}}". Otherwise, if you are able to provide the image then please do so. For guidance, see Wikisource:Image guidelines and Help:Adding images. |
Figure 3-6. Cosmonaut Vladimir Dezhurov of Rosaviakosmos, Expedition 3 flight engineer, works on a laptop computer in the temporary sleep station in the U.S. Laboratory.
Recent unpublished data from shuttle missions (Barger and Czeisler, 2008) also show a trend of regular use of medication to promote sleep. Of the first 32 crew members studied during 11 missions, 26 (81%) reported taking a sleep-promoting medication in flight. Crew members who used sleep medications reported taking them on approximately half the nights that data were collected aboard the space shuttle; two doses of sleep medication were taken on 7% of the nights when medication was used. The frequent use of sleep medication in flight serves as a strong indication that sleep is disturbed for some crew members.
Sleep structure (i.e., sleep quality) may also be altered in space. A 1997 study (Gundel et al.), which used polysomnography (Category II) to evaluate sleep content, found that latency to the first rapid eye movement (REM) episode was shorter, and slow wave sleep (SWS) was redistributed from the first to the second sleep cycle. Dijk et al. (2001), who also used polysomnography, found a reduction of SWS during the final third of in-flight sleep episodes and post-flight (evaluated at 2, 4, and 5 days post-landing), with an increase in sleep duration and the amount of restorative sleep.
Risk of Performance Errors Due to Sleep Loss, Circadian Desynchronization, Fatigue, and Work Overload
97